# Diabetes Drugs Ref

> Diabetes Drugs Ref (iPhone/iPad app by ATIF ELNIL.)

- Source: https://appshunter.io/ios/app/diabetes-drugs-ref/id6761283169 (this page in markdown: same URL + `.md`)
- Developer: [ATIF ELNIL](https://appshunter.io/developer/1886307011)
- Category: Medical, Education
- Price: Free with in-app purchases (on sale, was $9.99)
- Age rating: 17+
- Requires: iOS 16 · 18 MB
- Languages: American English
- Released: 2026-04-01
- Data updated: 2026-05-20
- User reviews in markdown: https://appshunter.io/ios/app/diabetes-drugs-ref/id6761283169/reviews.md

## What is Diabetes Drugs Ref?

Diabetes Drugs Reference — evidence-based pharmacology reference for diabetes drug classes. Based on NICE NG28 2022, ADA Standards of Care 2024, and SIGN 154.
FREE — no purchase needed:
— SGLT2 Inhibitors: empagliflozin, dapagliflozin, canagliflozin, ertugliflozin with doses, CV outcomes and renal thresholds
FULL ACCESS — £14.99/year unlocks:
— GLP-1 Receptor Agonists: semaglutide, liraglutide, dulaglutide, tirzepatide
— DPP-4 Inhibitors: sitagliptin, linagliptin, alogliptin, vildagliptin
— Metformin: doses, eGFR thresholds, B12 monitoring
— Sulfonylureas: gliclazide, glipizide, glibenclamide
— Insulin: basal, bolus, premixed, ultra-long analogues
— Thiazolidinediones, Meglitinides, Alpha-glucosidase inhibitors
— Prescribing Guide: renal dosing table, contraindications, monitoring
— HbA1c Targets: individualised targets by patient group
— CV Outcomes Trials: EMPA-REG, LEADER, DECLARE, DAPA-HF, REWIND, SURPASS
— Hypoglycaemia Management: severity grading, treatment protocol
— Sick Day Rules: SADMAN, JBDS inpatient protocol
— Special Situations: pregnancy, CKD, elderly, perioperative
— References: 25+ tappable citations, NICE, NEJM, Lancet, ADA
Subscription renews automatically at £14.99/year unless cancelled at least 24 hours before the end of the current period. Manage in App Store Settings > Subscriptions.
For use by qualified healthcare professionals only. Always verify doses against the current BNF and SmPC before prescribing.

## Pricing and in-app purchases

Base price: Free.

**One-time purchases**

| Purchase | Price | Type |
| --- | --- | --- |
| Diabetes Drugs Ref Pro | $14.99 | one-time |



## Version history (last 2 releases)

### 1.0.1 — 2026-05-11

Version 1.0.1: SGLT2 Inhibitors now permanently free. Full access to all 9 drug classes, CV outcomes trials, prescribing guide, sick day rules and special situations via annual subscription — £14.99/year.

### 1.0 — 2026-04-01

No release notes.

## More apps by ATIF ELNIL

- [Antiseizure Medications](https://appshunter.io/ios/app/antiseizure-medications/id6760823031)
- [NIHSS Calculator](https://appshunter.io/ios/app/nihss-calculator/id6760891744)
- [HyperRef Clinical](https://appshunter.io/ios/app/hyperref-clinical/id6760921930)
- [PD Drug Reference](https://appshunter.io/ios/app/pd-drug-reference/id6760972673)
- [MS DMT Reference](https://appshunter.io/ios/app/ms-dmt-reference/id6761038062)
- [ElectroBalance Pro](https://appshunter.io/ios/app/electrobalance-pro/id6761238034)

All apps by ATIF ELNIL: https://appshunter.io/developer/1886307011

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-05-20.*